Table 2.
Clinical characteristics of BC patients from TCGA.
| Clinical characteristics | Group | No. of case (%) |
|---|---|---|
| Age (year) | <60 | 588 (53.73) |
| ≥60 | 467 (46.27) 275 (26.07) 610 (57.82) |
|
| T stage | T1 | |
| T2 | ||
| T3 | 134 (12.70) | |
| T4 | 33 (3.13) | |
| Unknown | 3 (0.28) | |
| N stage | N0 | 499 (47.30) |
| N1 | 347 (32.89) | |
| N2 | 116 (11.0) | |
| N3 | 74 (7.01) | |
| Unknown | 19 (1.80) 879 (83.32) |
|
| M stage | M0 | |
| M1 | 20 (1.90) | |
| Unknown | 156 (14.79) | |
| Pathologic stage | I | 180 (17.06) |
| II | 597 (56.59) | |
| III | 236 (22.37) | |
| IV | 18 (1.71) | |
| Unknown | 24 (2.27) 770 (72.99) |
|
| ER status | Positive | |
| Negative | 237 (22.46) | |
| Unknown | 48 (4.55) | |
| PR status | Positive | 670 (63.51) |
| Negative | 334 (31.66) | |
| Unknown | 51 (4.83) | |
| HER2 status | Positive | 153 (14.50) 544 (51.56) |
| Negative | ||
| Unknown | 358 (33.93) | |
| Survival status | Alive | 908 (86.07) |
| Dead | 147 (13.93) |